Core Viewpoint - 圣桐特医 is applying for a listing on the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor, highlighting its growth and leadership in the specialized medical food market in China [1][4]. Company Overview - 圣桐特医 is recognized as one of China's leading providers of specialized medical foods, focusing on the development, production, and sales of these products [4]. - The company holds the top position among domestic specialized medical food brands in China, with a market share of 6.3% in the overall specialized medical food market and 9.5% in the infant specialized medical food segment [4]. Product Development - Since its establishment in 2005, 圣桐特医 has pioneered the specialized medical food sector in China, launching the first commercialized specialized medical food product in 2007 [4]. - The company has introduced 14 major specialized medical food products as of May 20, 2025, with 16 additional products currently in development [5]. Financial Performance - The revenue for 圣桐特医 has shown significant growth, with figures of approximately 491.2 million RMB in 2022, 654.2 million RMB in 2023, and projected 834.1 million RMB in 2024 [5][7]. - The adjusted net profit (non-IFRS) for the same periods was approximately 121 million RMB, 175 million RMB, and 199 million RMB, respectively [5][7].
新股消息 | 中国本土特医食品龙头圣桐特医递表港交所 目前已推出14款特医食品
智通财经网·2025-06-02 12:09